Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The MTA—rip it up and start again?

Nature Biotechnology volume 25, page 721 (2007)Cite this article

Securing material transfer agreements can be burdensome for academics and make downstream research prohibitively expensive, particularly for small startups with limited resources. Two technology-transfer professionals debate the pros and cons of such contracts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Katharine Ku is in the Office of Technology Licensing, Stanford University, 1705 El Camino Real, Palo Alto, California 94306-1106, USA katharine.ku@stanford.edu,

    Katharine Ku

  2. James Henderson is in the Office of Technology Management, University of California at San Francisco, 185 Berry Street, Suite 4603, San Francisco, California 94107, USA. james.henderson@ucsf.edu,

    James Henderson

Authors
  1. Katharine Ku
    View author publications

    Search author on:PubMed Google Scholar

  2. James Henderson
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ku, K., Henderson, J. The MTA—rip it up and start again?. Nat Biotechnol 25, 721 (2007). https://doi.org/10.1038/nbt0707-721a

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt0707-721a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing